CureVac is back in the Covid-19 vaccine game, this time with ‘lessons learned’

CureVac NV, a German biopharmaceutical company with U.S. headquarters in Boston, is back in the Covid-19 vaccine game — about a year after it abandoned its first attempt. The CEO detailed the company’s approach this time.